EPO Patents = 1

Trademarks = 13

Forward Citations = 34

Loading Chart...

11 inventors (with patents filed for the assignee):

Brendan Mark Johnson (6 out of 11 patents)

Vijaykumar Reddy Rajasekhar (6 out of 16 patents)

Lynn Seely (4 out of 9 patents)

4. Paul N Mudd, Jr (4 out of 10 patents)

5. David B MacLean (3 out of 6 patents)

6. Laura Ann Williams (2 out of 4 patents)

7. Mark Hibberd (1 out of 3 patents)

8. Masataka Tanimoto (1 out of 3 patents)

9. Mayukh Vasant Sukhatme (1 out of 3 patents)

10. Susan Wollowitz (1 out of 36 patents)

11. Jr Paul N Mudd (0 patent)

6 patents: Sort by Forward Citations

1. 11638740 - Methods of treating female infertility (2023-05-02),

2. 11583526 - Treatment of prostate cancer (2023-02-21),

3. 11033551 - Methods of treating uterine fibroids (2021-06-15),

4. 11013780 - Methods of treating female infertility (2021-05-25),

5. 10786501 - Treatment of prostate cancer (2020-09-29),

6. 10449191 - Treatment of prostate cancer (2019-10-22),

Myovant Sciences is a healthcare company focused on developing and commercializing innovative therapies for women's health and prostate cancer. The company's lead product candidate, relugolix, has the potential to transform the treatment landscape for multiple hormone-sensitive conditions. Myovant is committed to improving the lives of patients through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

6 Patents

#51 in Basel

#1,448 in Switzerland

Basel, Switzerland

Myovant Sciences Gmbh